| __timestamp | Viridian Therapeutics, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3243000 | 5903000 |
| Thursday, January 1, 2015 | 2472000 | 2762000 |
| Friday, January 1, 2016 | 2548000 | 1114000 |
| Sunday, January 1, 2017 | 19623000 | 25573000 |
| Monday, January 1, 2018 | 30421000 | 6000000 |
| Tuesday, January 1, 2019 | 32793999 | 38845000 |
| Wednesday, January 1, 2020 | 28304000 | 50523000 |
| Friday, January 1, 2021 | 620000 | 75463000 |
| Saturday, January 1, 2022 | 755000 | 105767000 |
| Sunday, January 1, 2023 | 1322000 | 167512000 |
Data in motion
In the competitive world of biotechnology, cost efficiency can be a decisive factor for success. This analysis compares the cost of revenue efficiency between Xenon Pharmaceuticals Inc. and Viridian Therapeutics, Inc. over the past decade. From 2014 to 2023, Xenon Pharmaceuticals has shown a remarkable upward trend, with its cost of revenue increasing by over 2,700%, reaching a peak in 2023. In contrast, Viridian Therapeutics experienced a more volatile journey, with a significant spike in 2017 and 2018, followed by a sharp decline, culminating in a modest 1.3 million in 2023.
This divergence highlights Xenon's strategic growth and operational scaling, while Viridian's fluctuating costs suggest a more turbulent path. Investors and industry analysts should consider these trends when evaluating the financial health and strategic direction of these companies.
Cost of Revenue Comparison: Merck & Co., Inc. vs Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Merck & Co., Inc. and Viridian Therapeutics, Inc.'s Expenses
Amgen Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Catalent, Inc. vs Viridian Therapeutics, Inc.
Analyzing Cost of Revenue: Jazz Pharmaceuticals plc and Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Cytokinetics, Incorporated and Xenon Pharmaceuticals Inc.'s Expenses
Cost of Revenue: Key Insights for Ionis Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Cost of Revenue Comparison: Xenon Pharmaceuticals Inc. vs Xencor, Inc.
Cost Insights: Breaking Down Supernus Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.'s Expenses
Cost Insights: Breaking Down Travere Therapeutics, Inc. and Viridian Therapeutics, Inc.'s Expenses
Analyzing Cost of Revenue: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.